• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

hair

new york stock exchange
Favicon Fierce Pharma

Veradermics locks in $256M IPO, shares spike

With an oversubscribed trading debut now in the books, Veradermics is well coiffed to tap into the growing opportunity for pattern hair loss drugs.
Fraiser Kansteiner Feb 5, 2026 10:01am
Hairbrush seamless pattern Retro hair combs ornament Trendy hair braiding accessor
Favicon Fierce Pharma

Veradermics grows hair loss med hopes on $150M funding wave

Oct 16, 2025 7:30am
hair braid

Pelage locks in $120M series B for hair growth program

Oct 15, 2025 7:00am
An image of a mole on human skin with hair sticking out of it

Do hairy moles hold the key to treating hair loss?

Jun 22, 2023 5:01am
Deal terminate tear up end deal scrap

AbbVie, Ipsen exit R&D deals to cap off lousy year for Exicure

Dec 14, 2022 7:15am
Financial data on a stock ticker

Chasing Lilly, Concert alopecia drug hits high notes in phase 3

May 23, 2022 9:05am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings